Rajfer S I
Merck Research Laboratories, Blue Bell, Pennsylvania.
J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):198A-200A. doi: 10.1016/0735-1097(93)90491-i.
Despite recent therapeutic advances, patients with heart failure have considerable morbidity and a markedly shortened life span. The prevalence of heart failure increases with age and is the most common cause of hospital admission in the elderly. In developing innovative remedies for this disorder, the scientific challenges, regulatory agencies' guidelines, physician behavior and marketing requirements must be considered.
